[1] Kurlan R.Tourette's syndrome[J].New England Journal of Medicine,2010,363(24):2332-2338.
[2] Knight T,Steeves T,Day L,et al.Prevalence of tic disorders:a systematic review and meta-analysis[J].Pediatric neurology,2012,47(2):77-90.
[3] Polanczyk G,de Lima M,Horta B,et al.The worldwide prevalence of ADHD:a systematic review and metaregression analysis[J].American journal of psychiatry,2007,164(6):942-948.
[4] Khalifa N,Von Knorring AL.Psychopathology in a Swedish population of school children with tic disorders[J].Journal of the AmericanAcademy of Child & Adolescent Psychiatry,2006,45(11):1346-1353.
[5] Scharf JM,Miller LL,Mathews CA,et al.Prevalence of Tourette syndrome and chronic tics in the population-based Avon longitudinal study of parents and children cohort[J].Journal of the American Academy of Child & Adolescent Psychiatry,2012,51(2):192-201.
[6] Sukhodolsky DG,Scahill L,Zhang H,et al.Disruptive behavior in children with Tourette's syndrome:association with ADHD comorbidity,tic severity,and functional impairment[J].Journal of the American Academy of Child & Adolescent Psychiatry,2003,42(1):98-105.
[7] Debes NMM,Hjalgrim H,Skov L.The presence of attention-deficit hyperactivity disorder (ADHD) and obsessive-compulsive disorder worsen psychosocial and educational problems in Tourette syndrome[J].Journal of Child Neurology,2010,25(2):171-181.
[8] Eddy CM,Rizzo R,Gulisano M,et al.Quality of life in young people with Tourette syndrome:a controlled study[J].Journal of Neurology,2011,258(2):291-301.
[9] Eddy CM,Rizzo R,Cavanna A E.Neuropsychological aspects of Tourette syndrome:a review[J].Journal of Psychosomatic Research,2009,67(6):503-513.
[10] Roessner V,Walitza S,Riederer F,et al.Tetrahydroisoquinoline derivatives:a new perspective on monoaminergic dysfunction in children with ADHD?[J].Behavioral and Brain Functions,2007,3(1):1-6.
[11] Shaw M,Hodgkins P,Caci H,et al.A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder:effects of treatment and non-treatment[J].BMC Medicine,2011,10(1):99-99.
[12] Volkow ND,Wang GJ,Newcorn J,et al.Brain dopamine transporter levels in treatment and drug naive adults with ADHD[J].Neuroimage,2007,34(3):1182-1190.
[13] Bloch MH,Panza KE,Landeros-Weisenberger A,et al.Meta-analysis:treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders[J].Journal of the American Academy of Child & Adolescent Psychiatry,2009,48(9):884-893.
[14] Gadow KD,Sverd J,Nolan EE,et al.Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder[J].Journal of the American Academy of Child & Adolescent Psychiatry,2007,46(7):840-848.
[15] Gaffney GR,Perry PJ,Lund BC,et al.Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome[J].Journal of the American Academy of Child & Adolescent Psychiatry,2002,41(3):330-336.
[16] Kollins SH,Jain R,Brams M,et al.Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD[J].Pediatrics,2011,127(6):e1406-e1413.
[17] Allen AJ,Kurlan RM,Gilbert DL,et al.Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders[J].Neurology,2005,65(12):1941-1949.
[18] Spencer TJ,Sallee FR,Gilbert DL,et al.Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome[J].Journal of Attention Disorders,2008,11(4):470-481.
[19] Singer HS,Brown J,Quaskey S,et al.The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome:a double-blind placebo-controlled study with clonidine and desipramine[J].Pediatrics,1995,95(1):74-81.
[20] Spencer T,Biederman J,Coffey B,et al.A double-blind comparison of desipramine and placebo in cChildren and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder[J].Archives of General Psychiatry,2002,59(7):649-656.
[21] Wenzel C,Kleimann A,Bokemeyer S,et al.Aripiprazole for the treatment of Tourette syndrome:A case series of 100 patients[J].Journal of Clinical Psychopharmacology,2012,32(4):548-550.
[22] Masi G,Gagliano A,Siracusano R,et al.Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder:a 12-week,open-label,preliminary study[J].Journal of Child and Adolescent Psychopharmacology,2012,22(2):120-125.